DEXTROAMP-AMPHET ER 30 MG CAP

What it is

DEXTROAMP-AMPHET ER 30 MG CAP is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate”, “dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate”, “dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate” and “dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine sulfate and amphetamine aspartate”, as its NDCs’ listings variously write the nonproprietary name, under the trade names “Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Extended-Release”, “Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate” and “Mixed Salts of a Single Entity Amphetamine Product XR”.

FDA gives its dosage form as “capsule” and “capsule, extended release” and its route as oral.

FDA lists 11 labelers (the companies named on the label) for its NDCs, among them Amneal Pharmaceuticals of New York LLC, Actavis Pharma, Inc. and SpecGx LLC.

FDA’s Established Pharmacologic Class for it is Central Nervous System Stimulant.

The NADAC file of 2026-10-14 prices it under 11 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $13.97 for 30 capsules (30 × $0.46559 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

What NADAC measures · Why 30 capsules · NADAC explanation codes

The 11 labelers

Other strengths, forms and brands

22 other products in the NADAC file share an FDA nonproprietary name with DEXTROAMP-AMPHET ER 30 MG CAP.

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 11 NDCs’ NADAC prices is $0.46559 per EA filed.

Of the 203 other products in FDA’s Central Nervous System Stimulant class priced per EA, 167 have a higher middle NADAC price and 36 a lower one. The one in the middle is FOCALIN XR 5 MG CAPSULE, at $4.70352 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

We don’t know yet; the card above says why.

Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

• What is your cash price for 30 capsules? Is it lower than what I would pay through my insurance?
• These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.